The search for better cancer treatments remains a top global priority. While survival rates have improved significantly for several cancers over recent decades, many forms still have poor outcomes, and access to life-saving care is uneven worldwide.
Progress and Challenges in Cancer Care
According to the World Health Organization, more than 50 million people alive today were diagnosed with cancer in the last five years. In the UK, cancer mortality rates have dropped by nearly a quarter since the early 1970s. However, hundreds of thousands of people still die each year from treatable forms of the disease, and healthcare systems face growing burdens.
Andrew Gregory, the Guardian's health editor, recently attended the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, where over 40,000 experts gathered to discuss the latest in cancer research. He notes that progress is often incremental, as cancer encompasses more than 200 distinct diseases, each requiring unique approaches.
Breakthroughs in Pancreatic Cancer
Pancreatic cancer remains one of the deadliest, with only a 1% survival rate beyond three years once it spreads. A new daily pill has doubled survival time in a 500-person trial, extending life from about six and a half months to 13 and a half months. While not a cure, experts call it a 'gamechanger' and a significant first step.
Smart Drugs Expose Hidden Cancer Cells
Immunotherapy has made strides, but many tumours can 'hide' from treatment. Early trials of a new smart drug have shrunk tumours by at least 30% in six common cancers by removing the 'invisibility cloak' that protects cancer cells. The drug helps the immune system pinpoint and destroy tumours. Further large-scale studies are needed.
Weight Loss Drugs Show Promise
GLP-1 medications, used for weight loss, have shown an association with reduced cancer risk. Studies found users were 30% less likely to develop breast cancer and up to half as likely to see their cancer spread. However, these observational studies do not yet prove causation, and more research is needed to understand the mechanisms.
Despite the promising developments, experts caution that many treatments are years away from widespread availability. The conference highlights the ongoing effort to improve survival rates for millions affected by cancer worldwide.
